Assertion on new methods to progress agency’s continued evaluation of prospective regulatory pathways for cannabis-that contains and cannabis-derived products and solutionsHowever, based on readily available evidence, FDA has concluded that none of those is the case for THC or CBD. FDA has hence concluded that it is a prohibited act to introduce